Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of BP180 and BP230 Autoantibodies in Pruritus Under Immunotherapy
NCT05689463Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Feb 2023
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Rouen University Hospital. Primary endpoint: Number of patients with positive anti BP180 and/or anti BP230 serology at 1 day. Started Feb 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05689463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05689463.